Novavax (NVAX) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Novavax (NVAX) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
-103.50% |
| Date | Value |
|---|
| Mar 31, 2026 |
-103.50% |
| Dec 31, 2025 |
114.14% |
| Sep 30, 2025 |
-2.64% |
| Jun 30, 2025 |
-52.87% |
| Mar 31, 2025 |
355.68% |
| Dec 31, 2024 |
61.24% |
| Sep 30, 2024 |
28.00% |
| Jun 30, 2024 |
118.91% |
| Mar 31, 2024 |
51.38% |
| Dec 31, 2023 |
15.88% |
| Sep 30, 2023 |
-44.04% |
| Jun 30, 2023 |
122.91% |
| Mar 31, 2023 |
-268.83% |
| Dec 31, 2022 |
66.99% |
| Sep 30, 2022 |
48.53% |
| Jun 30, 2022 |
-33.69% |
| Mar 31, 2022 |
199.56% |
| Dec 31, 2021 |
-240.61% |
| Sep 30, 2021 |
-36.30% |
| Jun 30, 2021 |
-1,058.13% |
